IDO1 and neoplasm: In hepatocellular carcinoma, tumor-associated fibroblasts suppress hepatic NK cell activity through IDO and prostaglandin E2 (PGE2, an immunosuppressive lipid product of arachidonic acid metabolism) secretion [92] and can be reversed or palliated by anti-IDO [93].